Apollo

Select Address

Search Medicines
  1. Home
  2. Bracanat 150 Tablet

  3. Bracanat 150 Tablet Substitute

Bracanat 150 Tablet Substitute

Medicine Composition:

OLAPARIB-150MG

All Substitutes & Brand Comparisons

call Doctor

When Should You Consider Switching from Bracanat 150 Tablet ?

Patients may explore substitutes in the following scenarios:

  • High monthly cost of Bracanat 150 Tablet
  • Non-availability in local pharmacies
  • Generic recommendation by a doctor
  • Side effects or better tolerability with alternatives

What to Know Before Switching

Before you switch from Bracanat 150 Tablet to another medicine, here are some important points to keep in mind:

bannner image

Same salt, different brands:

Most substitutes contain the same active ingredient - OLAPARIB-150MG, but the fillers, coating, or manufacturing quality may vary slightly.

bannner image

Consult your doctor first:

Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.

bannner image

Watch out for allergies or reactions:

Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.

bannner image

Price ≠ effectiveness:

A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.

bannner image

Check the dosage form and strength:

Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.

Uses

Bracanat 150 Tablet is used in the treatment of Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. The detailed uses of Bracanat 150 Tablet are as follows:

  • Ovarian Cancer: Bracanat 150 Tablet helps in maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer after response to platinum-based chemotherapy and especially effective in patients with BRCA mutations or homologous recombination deficiency (HRD).
  • Breast Cancer: Bracanat 150 Tablet is used for HER2-negative, BRCA-mutated metastatic or high-risk early breast cancer and used after chemotherapy and sometimes endocrine therapy.
  • Pancreatic Cancer: Bracanat 150 Tablet helps in maintenance treatment for germline BRCA-mutated metastatic pancreatic cancer that hasn’t progressed after platinum-based chemotherapy.
  • Prostate Cancer: Bracanat 150 Tablet is for BRCA-mutated metastatic castration-resistant prostate cancer, often after prior hormonal therapy.

Medicinal Benefits

Bracanat 150 Tablet belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate.  Bracanat 150 Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.

FAQs

The substitutes of Bracanat 150 Tablet contain the same active salt(s) - OLAPARIB-150MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Bracanat 150 Tablet is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Bracanat 150 Tablet are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Bracanat 150 Tablet meet the same safety and efficacy standards as Bracanat 150 Tablet , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Bracanat 150 Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Bracanat 150 Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Bracanat 150 Tablet for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Bracanat 150 Tablet is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Bracanat 150 Tablet to its substitute. Always consult your doctor before switching.
Bracanat 150 Tablet is used to treat ovarian, breast, pancreatic, and prostate cancers.
Bracanat 150 Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells to repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
If you are allergic to Olaparib or any other ingredients in this medication, are breastfeeding, or have too low blood cell counts, you should not use Bracanat 150 Tablet .
Yes, Bracanat 150 Tablet can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or have an infection.
Do not have immunizations/vaccinations without talking to your doctor first. Also, avoid contact with people who recently had immunizations /vaccinations.
Bracanat 150 Tablet is not a traditional chemotherapy pill. It's a targeted therapy, also known as a PARP inhibitor, which works differently from chemotherapy.
When taking Bracanat 150 Tablet , avoid or limit foods high in grapefruit or grapefruit juice, as these can interact with the medication. Additionally, consult your doctor or pharmacist for personalized dietary advice.
The duration of Bracanat 150 Tablet treatment can vary depending on the type of cancer being treated and the patient's response to the medication. Generally, Bracanat 150 Tablet is taken until disease progression, unacceptable toxicity, or completion of a specified treatment period. Therefore, follow your doctor's instructions carefully.
Before taking Bracanat 150 Tablet , inform your doctor about all your medical conditions, sensitivities, and medications. Also, mention if you're pregnant, planning to become pregnant, or breastfeeding. This will ensure safe use and help avoid any potential interactions.
Bracanat 150 Tablet can interact with other medications, so do not use any other medications unless your doctor advises. Your doctor will check for potential interactions and advise you on how to take them safely with Bracanat 150 Tablet .
No, Bracanat 150 Tablet is not recommended for use during pregnancy and breastfeeding, and it causes unwanted side effects. However, please consult your doctor if you have any concerns.
The common side effects of Bracanat 150 Tablet are feeling very tired, pale skin, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Please consult your doctor if any of these side effects persist or worsen.
Apollo 247 Floating Button

Buy best Neoplastic Disorders products by